The range of medical imaging capabilities available within this Unit allow for large animal diagnostic imaging, with the possibility to integrate all the information on body organs,systems, specific diseases or animal models, etc., that can be obtained with different imaging systems,such as clinical grade Magnetic Resonance Imaging, ultrasonography CT and fluoroscopy. This Unit is highly focused on cardiovascular diseases imaging and therapy, offering a comprehensive cardiac minimally invasive service ranging from disease modeling to therapy evaluation. Regulatory requirements prior to introducing a new medical diagnostic or therapeutic technology in clinical practice determine a mandatory preclinical validation in animal models; an scenario for which this Unit is especially suited.
FOR THOSE SERVICES IDENTIFIED AS OUTSTANDING, AT LEAST 20% OF THEIR CAPACITY IS OPEN UNDER COMPETITIVE ACCESS. SEE ANNEX 1 OF ACCESS PROTOCOL FOR DETAILS ON % OF OPENNESS FOR EACH SERVICE
|Title||Fundin: Organism||Call: Funding source||Role|
|SAF2017-90810-REDI||Strategic Promotion and coordinated management of Nanbiosis: Pronanbiosis II||Agencia Estatal de Investigación (AEI)||Acciones de dinamización «REDES DE EXCELENCIA» -ICTS 2017||Partner|
|PICCOLO-732111||Multimodal highly-sensitive PhotonICs endoscope for improve in vivo COLOn Cancer diagnosis and clinical decision support||European Commission-H2020||H2020-ICT-2016-1||Partner|
|0624_2IQBIONEURO_6_E||Promotion of an R&I network in biological chemistry for the diagnosis and treatment of neurological diseases||European Union Interreg : European Territorial Co-operation||POCTEP Interreg España-Portugal||Partner|